Marquette Asset Management’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.58K Sell
20
-52
-72% -$4.42K ﹤0.01% 660
2026
Q1
$6.2K Buy
72
+46
+177% +$4.13K ﹤0.01% 318
2025
Q4
$2.27K Buy
+26
New +$1.97K ﹤0.01% 463

Other funds holding GMED

Marquette Asset Management's GMED Position: Q2 2026 in Review

Marquette Asset Management reduced its Globus Medical (GMED) stake by 72% in Q2 2026, selling an estimated $4.42K and leaving 20 shares worth $1.58K. The position accounts for ﹤0.01% of the portfolio, ranked #660.

Marquette Asset Management first reported a position in GMED in Q4 2025 and has held it in 3 quarters since. The position peaked at $6.2K in Q1 2026. 601 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Marquette Asset Management held 20 shares of Globus Medical worth $1.58K as of Q2 2026.
  • Marquette Asset Management sold 52 Globus Medical shares in Q2 2026, an estimated $4.42K.
  • Globus Medical made up ﹤0.01% of Marquette Asset Management's portfolio in Q2 2026, its #660 holding.
  • Marquette Asset Management first reported a position in Globus Medical in Q4 2025 and has held it in 3 quarters since.
  • Marquette Asset Management's Globus Medical position peaked at $6.2K in Q1 2026.
  • 601 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Marquette Asset Management's 13F filing for Q2 2026, filed 9 Jul 2026.